Imaging Investigation on the Evolution and Prognosis of Moyamoya Disease

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

To investigate the evolution of imaging appearances and cognitive function of Moyamoya disease (MMD) and to establish a prognosis evaluation system based on imaging biomarkers in MMD. The study may be helpful to optimize and improve the diagnosis and pretreatment assessment of MMD, and provide an important theoretical supplement to the existing guidelines for the management of MMD.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 10
Maximum Age: 60
View:

• Patients with MMD: Conventional angiography or MRI examination conforms to the Guidelines for Diagnosis and Treatment of MMD (Neurol Med Chir (Tokyo) 52, 245-266, 2012), It is characterized by stenosis or occlusion of the end of the internal carotid artery, anterior cerebral artery and/or the beginning of the middle cerebral artery of unknown cause, accompanied by dilatation of the perforating artery at the base of the brain or of capillaries on the surface of the brain, i.e., the formation of smoke vessels. Sign the informed consent. Older than 10 and younger than 60. The education level of patients reached primary school or above (years of education ≥6).

Locations
Other Locations
China
Chinese PLA General Hospital
RECRUITING
Beijing
Contact Information
Primary
Jinhao Lyu
330322990@qq.com
+8615903562929
Time Frame
Start Date: 2022-09-01
Estimated Completion Date: 2027-12-31
Participants
Target number of participants: 300
Treatments
Medical treatment group
Conservative medical treatment
Surgical treatment group
Direct revascularization, indirect revascularization or combined revascularization
Related Therapeutic Areas
Sponsors
Leads: Chinese PLA General Hospital
Collaborators: Beijing Tiantan Hospital

This content was sourced from clinicaltrials.gov